Beacon Therapeutics may have found a guiding light in a disease area where other companies have stumbled with its laruparetigene zovaparvovec (laru-zova), a gene therapy that proved early improvements ...

Please provide your email address to receive an email when new articles are posted on . Atsena Therapeutics completed patient dosing in part A of the phase 1/2 LIGHTHOUSE clinical trial investigating ...

Genetic diseases are a compelling target for viral gene therapy, but the results can be spotty at best. There's good news, though. On Wednesday, researchers presented evidence from a breakthrough gene ...

(CNN) — For her entire life, college student Olivia Cook had only a small degree of central vision. It was as if she was watching the world through a straw hole, and in dimly lit places, she could not ...

A man born with Usher syndrome type 1b, a rare genetic disease that causes congenital deafness and progressive blindness, has reportedly experienced “substantial improvement” in his vision, after ...

Color blindness, or color vision deficiency, is more common in males. This is due to how parents pass down a chromosome associated with the male sex. Red-green color vision deficiency is the most ...

Most individuals with color vision deficiency have had it since birth. However, people can develop it later in life. If it develops due to a health problem, color blindness can worsen over time. Color ...